|
DE69633196D1
(de)
*
|
1995-10-16 |
2004-09-23 |
Fujisawa Pharmaceutical Co |
Heterocyclische verbindungen als h+-atpasen
|
|
GB9712761D0
(en)
*
|
1997-06-17 |
1997-08-20 |
Chiroscience Ltd |
Quinolines and their therapeutic use
|
|
US6262070B1
(en)
|
1998-11-04 |
2001-07-17 |
Darwin Discovery Ltd. |
Heterocyclic compounds and their therapeutic use
|
|
GB9824160D0
(en)
*
|
1998-11-04 |
1998-12-30 |
Darwin Discovery Ltd |
Heterocyclic compounds and their therapeutic use
|
|
ATE320800T1
(de)
|
1999-08-21 |
2006-04-15 |
Altana Pharma Ag |
Synergistische kombination von roflumilast und salmeterol
|
|
AU1053501A
(en)
*
|
1999-11-02 |
2001-05-14 |
Ajinomoto Co., Inc. |
Polyazanaphthalene compound and medicinal use thereof
|
|
JP4603646B2
(ja)
*
|
1999-11-15 |
2010-12-22 |
富士フイルムファインケミカルズ株式会社 |
新規なジピリジル誘導体
|
|
US7217722B2
(en)
*
|
2000-02-01 |
2007-05-15 |
Kirin Beer Kabushiki Kaisha |
Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
|
|
GB0003256D0
(en)
*
|
2000-02-11 |
2000-04-05 |
Darwin Discovery Ltd |
Heterocyclic compounds and their therapeutic use
|
|
US6521618B2
(en)
|
2000-03-28 |
2003-02-18 |
Wyeth |
3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
|
|
DE10035928A1
(de)
*
|
2000-07-21 |
2002-03-07 |
Asta Medica Ag |
Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
|
|
US7112594B2
(en)
|
2000-08-09 |
2006-09-26 |
Mitsubishi Pharma Corporation |
Fused bicyclic amide compounds and medicinal use thereof
|
|
US6953774B2
(en)
|
2000-08-11 |
2005-10-11 |
Applied Research Systems Ars Holding N.V. |
Methods of inducing ovulation
|
|
JP2002300373A
(ja)
*
|
2001-03-30 |
2002-10-11 |
Minolta Co Ltd |
画像処理方法、画像処理装置、記録媒体及びプログラム
|
|
EP1389467B1
(en)
*
|
2001-05-23 |
2013-07-03 |
Mitsubishi Tanabe Pharma Corporation |
Therapeutic composition for the regenerative treatment of cartilage diseases
|
|
CA2447619A1
(en)
*
|
2001-05-23 |
2002-11-28 |
Tanabe Seiyaku Co., Ltd. |
A composition for accelerating bone fracture healing
|
|
ATE341545T1
(de)
|
2001-07-16 |
2006-10-15 |
Astrazeneca Ab |
Quinolin-derivate und ihre verwendung als inhibitoren der tyrosine kinase
|
|
BR0212186A
(pt)
*
|
2001-08-15 |
2004-10-05 |
Du Pont |
Composto, composição e método para controle de pragas invertebradas
|
|
KR20040075004A
(ko)
|
2001-12-14 |
2004-08-26 |
어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. |
비폴리펩티드 고리에이엠피 레벨 모듈레이터를 이용한배란 유도 방법
|
|
MY140561A
(en)
|
2002-02-20 |
2009-12-31 |
Nycomed Gmbh |
Dosage form containing pde 4 inhibitor as active ingredient
|
|
SE0200920D0
(sv)
*
|
2002-03-25 |
2002-03-25 |
Astrazeneca Ab |
Novel compounds
|
|
ES2195785B1
(es)
*
|
2002-05-16 |
2005-03-16 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de piridazin-3(2h)-ona.
|
|
AU2002950217A0
(en)
|
2002-07-16 |
2002-09-12 |
Prana Biotechnology Limited |
8- Hydroxy Quinoline Derivatives
|
|
ES2211344B1
(es)
*
|
2002-12-26 |
2005-10-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de piridazin-3(2h)-ona.
|
|
TWI324150B
(en)
*
|
2003-02-28 |
2010-05-01 |
Novartis Ag |
Process for preparing 5-[(r)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-(1h)-quinolin-2-one salt
|
|
JP2006522151A
(ja)
|
2003-04-01 |
2006-09-28 |
アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ |
不妊症におけるホスホジエステラーゼ阻害剤
|
|
PE20050211A1
(es)
*
|
2003-04-02 |
2005-04-27 |
Novartis Ag |
Procedimiento para preparar oxi-(1h)-quinolin-2-onas 5-(alfa-haloacetil)-8-sustituidas
|
|
BRPI0410739A
(pt)
*
|
2003-05-29 |
2006-06-27 |
Astrazeneca Ab |
composição farmacêutica compreendendo um antagonista do receptor p2x7 e um fator de necrose tumoral (alfa)
|
|
US20070281931A1
(en)
*
|
2003-05-29 |
2007-12-06 |
Nigel Boughton-Smith |
Pharmaceutical Composition Containing a P2x7 Receptor Antagonist and Methotrexate
|
|
EP1644041A1
(en)
*
|
2003-05-29 |
2006-04-12 |
AstraZeneca AB |
A pharmaceutical composition comprising a p2x7 antagonist and sulfasalazine
|
|
GB0312609D0
(en)
*
|
2003-06-02 |
2003-07-09 |
Astrazeneca Ab |
Novel compounds
|
|
SE0302139D0
(sv)
*
|
2003-07-28 |
2003-07-28 |
Astrazeneca Ab |
Novel compounds
|
|
SE0302192D0
(sv)
*
|
2003-08-08 |
2003-08-08 |
Astrazeneca Ab |
Novel compounds
|
|
EP1664024B1
(en)
*
|
2003-09-15 |
2007-07-11 |
Schering Corporation |
Synthesis of quinoline 5-carboxamides useful for the preparation of pde iv inhibitors
|
|
SE0302488D0
(sv)
*
|
2003-09-18 |
2003-09-18 |
Astrazeneca Ab |
New combination
|
|
AR047329A1
(es)
|
2003-12-12 |
2006-01-18 |
Wyeth Corp |
Derivados de quinolinas para el tratamiento de enfermedades cardiovasculares. composiciones farmaceuticas
|
|
CN1921885B
(zh)
|
2003-12-26 |
2013-06-12 |
萩原正敏 |
苯胺衍生物或其可药用的盐在制备用于治疗患者病毒感染的药物中的用途
|
|
AU2005214159A1
(en)
*
|
2004-02-04 |
2005-09-01 |
Pfizer Products Inc. |
Substituted quinoline compounds
|
|
JP4787240B2
(ja)
*
|
2004-04-01 |
2011-10-05 |
ユニベルシテ・ド・リエージュ |
ピリミジン−２，４，６−トリオンのシクロデキストリン包接複合体
|
|
KR100907354B1
(ko)
*
|
2004-05-18 |
2009-07-10 |
쉐링 코포레이션 |
Ｐｄｅ4 억제제로서 유용한 치환된 2-퀴놀릴-옥사졸
|
|
ES2251866B1
(es)
*
|
2004-06-18 |
2007-06-16 |
Laboratorios Almirall S.A. |
Nuevos derivados de piridazin-3(2h)-ona.
|
|
ES2251867B1
(es)
*
|
2004-06-21 |
2007-06-16 |
Laboratorios Almirall S.A. |
Nuevos derivados de piridazin-3(2h)-ona.
|
|
GB0413960D0
(en)
*
|
2004-06-22 |
2004-07-28 |
Novartis Ag |
Organic compounds
|
|
PL2489659T3
(pl)
|
2004-06-24 |
2018-06-29 |
Vertex Pharma |
Modulatory transporterów posiadających kasetę wiążącą atp
|
|
US8354427B2
(en)
|
2004-06-24 |
2013-01-15 |
Vertex Pharmaceutical Incorporated |
Modulators of ATP-binding cassette transporters
|
|
SA05260265A
(ar)
*
|
2004-08-30 |
2005-12-03 |
استرازينيكا ايه بي |
مركبات جديدة
|
|
JP5139066B2
(ja)
*
|
2004-10-12 |
2013-02-06 |
アクテリオン ファーマシューティカルズ リミテッド |
結晶性硫酸塩としての１−［２−（４−ベンジル−４−ヒドロキシ−ピペリジン−１−イル）−エチル］−３−（２−メチル−キノリン−４−イル）−尿素
|
|
ATE517882T1
(de)
*
|
2004-10-19 |
2011-08-15 |
Hoffmann La Roche |
Chinolinderivate
|
|
SE0402925D0
(sv)
*
|
2004-11-30 |
2004-11-30 |
Astrazeneca Ab |
Novel Compounds
|
|
US8686002B2
(en)
|
2005-08-21 |
2014-04-01 |
AbbVie Deutschland GmbH & Co. KG |
Heterocyclic compounds and their use as binding partners for 5-HT5 receptors
|
|
EP1928437A2
(en)
|
2005-08-26 |
2008-06-11 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation
|
|
EP2258357A3
(en)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenesis with acetylcholinesterase inhibitor
|
|
AU2006304787A1
(en)
|
2005-10-21 |
2007-04-26 |
Braincells, Inc. |
Modulation of neurogenesis by PDE inhibition
|
|
WO2007053596A1
(en)
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
JP2009521468A
(ja)
*
|
2005-12-24 |
2009-06-04 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ａｂｃ輸送体の調節因子としてのキノリン−４−オン誘導体
|
|
PL1993360T3
(pl)
|
2005-12-28 |
2017-08-31 |
Vertex Pharmaceuticals Incorporated |
Stałe postacie n-[2,4-bis(1,1-dimetyloetylo)-5-hydroksyfenylo]-1,4- dihydro-4-oksochinolino-3-karboksyamidu
|
|
KR100821649B1
(ko)
*
|
2006-01-24 |
2008-04-11 |
서울시립대학교 산학협력단 |
클리오퀴놀을 유효성분으로 포함하는 ＨＩＦ-1α 활성제
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
EP2382975A3
(en)
|
2006-05-09 |
2012-02-29 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
BRPI0712915A2
(pt)
*
|
2006-07-11 |
2012-10-09 |
Schering Corp |
sal de xinafoato de um composto de 5-oxazal-2-il-quinolina substituìdo
|
|
US20100056791A1
(en)
|
2006-09-01 |
2010-03-04 |
Yasushi Kohno |
Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor containing the same
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
CL2007003874A1
(es)
*
|
2007-01-03 |
2008-05-16 |
Boehringer Ingelheim Int |
Compuestos derivados de benzamida; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar enfermedades cardiovasculares, hipertension, aterosclerosis, reestenosis, ictus, insuficiencia cardiaca, lesion isquemica, hipertensio
|
|
ES2306595B1
(es)
*
|
2007-02-09 |
2009-09-11 |
Laboratorios Almirall S.A. |
Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2.
|
|
ES2320954B1
(es)
*
|
2007-03-02 |
2010-03-16 |
Laboratorio Almirall S.A. |
Nuevo procedimiento de preparacion de 3-metil-4-fenilisoxazolo (3,4-d)iridazin-7(6h)-ona.
|
|
CN101679350B
(zh)
*
|
2007-03-22 |
2014-03-12 |
阿斯利康(瑞典)有限公司 |
用于治疗炎性疾病的喹啉衍生物
|
|
US9321730B2
(en)
*
|
2007-08-21 |
2016-04-26 |
The Hong Kong Polytechnic University |
Method of making and administering quinoline derivatives as anti-cancer agents
|
|
US9493419B2
(en)
|
2007-08-21 |
2016-11-15 |
The Hong Kong Polytechnic University |
Quinoline derivatives as anti-cancer agents
|
|
PE20091036A1
(es)
|
2007-11-30 |
2009-08-15 |
Astrazeneca Ab |
Derivado de quinolina como antagonista del receptor p2x7
|
|
US20100074949A1
(en)
|
2008-08-13 |
2010-03-25 |
William Rowe |
Pharmaceutical composition and administration thereof
|
|
US12458635B2
(en)
|
2008-08-13 |
2025-11-04 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical composition and administrations thereof
|
|
US20100216805A1
(en)
|
2009-02-25 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
ES2654414T3
(es)
|
2009-03-20 |
2018-02-13 |
Vertex Pharmaceuticals Incorporated |
Proceso de preparación de moduladores del regulador de la conductancia transmembrana de la fibrosis quística
|
|
JP2011042643A
(ja)
*
|
2009-07-24 |
2011-03-03 |
Bayer Cropscience Ag |
殺虫性カルボキサミド類
|
|
UY33372A
(es)
|
2010-05-10 |
2011-12-30 |
Gilead Sciences Inc |
?análogos de quinolina bi?funcionales, su uso en la manufactura de medicamentos,composiciones que los comprenden y procesos de preparacion?.
|
|
UY33373A
(es)
|
2010-05-10 |
2011-12-30 |
Gilead Sciences Inc |
?Compuestos de pirazolopiridina bifuncionales, su uso en terapia y composiciones que los comprenden?.
|
|
WO2013074059A2
(en)
*
|
2010-11-05 |
2013-05-23 |
Regents Of The University Of Minnesota |
Cytosine deaminase modulators for enhancement of dna transfection
|
|
US8802700B2
(en)
|
2010-12-10 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
|
EP2804603A1
(en)
|
2012-01-10 |
2014-11-26 |
President and Fellows of Harvard College |
Beta-cell replication promoting compounds and methods of their use
|
|
BR112014021090B1
(pt)
|
2012-02-27 |
2023-01-24 |
Vertex Pharmaceuticals Incorporated |
Composição farmacêutica e uso de n-[2,4-bis(1,1-dimetiletil)-5-hidróxifenil]-1,4-di-hidro-4-oxoquinolina3-carboxamida na preparação da mesma
|
|
CN103285373A
(zh)
*
|
2013-05-30 |
2013-09-11 |
苏州普罗达生物科技有限公司 |
肿瘤坏死因子-α多肽抑制剂制备及其应用
|
|
CN103254291B
(zh)
*
|
2013-05-30 |
2014-06-25 |
常州亚当生物技术有限公司 |
肿瘤坏死因子-α多肽抑制剂及其应用
|
|
PE20160608A1
(es)
*
|
2013-10-14 |
2016-07-08 |
Eisai Randd Man Co Ltd |
Compuestos de quinolina selectivamente sustituida
|
|
ES2702288T3
(es)
|
2014-10-07 |
2019-02-28 |
Vertex Pharma |
Co-cristales de moduladores de regulador de conductancia transmembrana de la fibrosis quística
|
|
RU2624906C2
(ru)
*
|
2015-12-22 |
2017-07-10 |
федеральное государственное бюджетное учреждение "Федеральный научно-исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации |
Производные 2-хинальдинкарбоновой кислоты и их противогриппозная активность
|
|
WO2019053015A1
(en)
|
2017-09-13 |
2019-03-21 |
Syngenta Participations Ag |
MICROBIOCIDE DERIVATIVES OF QUINOLINE (THIO) CARBOXAMIDE
|
|
CN107812006A
(zh)
*
|
2017-11-13 |
2018-03-20 |
全椒先奇医药科技有限公司 |
一种治疗急性肾衰药物组合物及其应用
|